SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
community-acquired infections / microbiology
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
33
1
Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection
2
Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles
3
Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives
4
Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women
5
Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization
6
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity
7
Community acquired pneumonia--a prospective UK study
8
Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen
9
Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples
10
Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus
11
Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus--an emerging problem for the management of skin and soft tissue infections
12
Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods
13
Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia
14
Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection
15
Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia
16
Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus
17
Methicillin-resistant Staphylococcus aureus disease in three communities
18
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
19
Septic pulmonary emboli and bacteremia associated with deep tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus
20
Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR
21
Epidemiology of dermatitis and skin infections in United States physicians' offices, 1993-2005
22
Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study Group
23
Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection
24
Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial
25
High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections
26
Bacteremia among children admitted to a rural hospital in Kenya
27
The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia
28
Home management of mild to moderately severe community-acquired pneumonia: a randomised controlled trial
29
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines
30
The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis
31
The value and complications of percutaneous transthoracic lung aspiration for the etiologic diagnosis of community-acquired pneumonia
32
Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group
33
Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group